The first PCM4EU podcast episodes are live!

In episode 2 and 3, we meet Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, PhD and Pharmacist, Medicine & Society at CZ Health Insurance and Member of the National Payer’s Evaluation Committee for Specialized Medicines and Companion Diagnostics (CieBAG). This committee decides on the reimbursement of medicines and molecular diagnostics in The Netherlands. Furthermore, she is affiliated with Leiden University Medical Center. In episode 2, Sahar talks about pragmatic reimbursement in DRUP-like clinical trials and in episode 3, access and funding of Molecular Tumor Boards are addressed, using The Netherlands as an example.

PCM4EU is happy to announce that the first four episodes in our podcast series are now available both on the PCM4EU YouTube channel and on our training webpages.